. Author manuscript; available in PMC: 2018 Jun 1.

Published in final edited form as: J Mol Cell Cardiol. 2017 Apr 27;107:41–51. doi: 10.1016/j.yjmcc.2017.04.004

Table 1D.

Hemodynamic parameters EDC treatment in csERagr;-WT and cs-ERα-KO

Heart samples			Pre-ischemic equilibration			Post-ischemic/End of reperfusion

	(n)	Body weight (g)	FR (ml/min)	HR (bpm)	LVDP (cmH₂O)	FR (ml/min)	HR (bpm)	LVDP (cmH₂O)
cs-ERαWT	8	24±1	2.4±0.3	376±25	144±11	1.7±0.1	328±17	57±6^#
cs-ERαWT + EDC	9	23±1	2.9±0.3	377±17	143±6	1.9±0.1	339±9	77±4
cs-ERαKO	5	21±1	2.5±0.2	388±23	148±10	1.8±0.1	325±20	67±9^#
cs-ERαKO + EDC	7	22±1	2.8±0.3	375±24	135±9	1.8±0.1	336±20	98±7

Values are mean ± SE; (n), number of hearts; FR, flow rate (ml/min); HR, heart rate (beats per min, bpm); LVDP, left ventricular developed pressure.

p<0.05 vs the same genotype + EDC.